Literature DB >> 25461237

Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever.

Onder Ergonul1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25461237     DOI： 10.1016/j.ijid.2014.08.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


× No keyword cloud information.
  5 in total

1.  Is the brain spared in Crimean-Congo haemorrhagic fever? An MR-SWI study to reveal CNS involvement.

Authors:  Bilge Öztoprak; İbrahim Öztoprak; Aynur Engin
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

Review 2.  Recent advances in understanding Crimean-Congo hemorrhagic fever virus.

Authors:  David W Hawman; Heinz Feldmann
Journal:  F1000Res       Date:  2018-10-29

Review 3.  Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.

Authors:  Aura R Garrison; Darci R Smith; Joseph W Golden
Journal:  Viruses       Date:  2019-06-28       Impact factor: 5.048

Review 4.  Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.

Authors:  Haleh Rezaee; Fariba Pourkarim; Samira Pourtaghi-Anvarian; Taher Entezari-Maleki; Touraj Asvadi-Kermani; Masoud Nouri-Vaskeh
Journal:  Pharmacol Res Perspect       Date:  2021-02

5.  Ribavirin use in pediatric patients with Crimean Congo Hemorrhagic Fever: is it really necessary?

Authors:  Hasan Tezer; Aslinur Ozkaya-Parlakay; Belgin Gulhan; Saliha Kanik-Yuksek
Journal:  Braz J Infect Dis       Date:  2016-02-02       Impact factor: 3.257
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.